Literature DB >> 5424352

Effects of ergocornine and 2-Br-alpha-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice.

R Yanai, H Nagasawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5424352     DOI: 10.1007/bf01898742

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  8 in total

1.  Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.

Authors:  L Varga; P M Lutterbeck; J S Pryor; R Wenner; H Erb
Journal:  Br Med J       Date:  1972-06-24

2.  Effects of 2-Br- -ergocryptine on plasma prolactin level and milk yield in cows.

Authors:  H Karg; D Schams; V Reinhardt
Journal:  Experientia       Date:  1972-05-15

3.  Effect of 2-Br- -ergocryptine on fresh water survival in the teleosts, Xiphophorus hellerii and Poecilia latipinna.

Authors:  B A McKeown
Journal:  Experientia       Date:  1972-06-15

4.  Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-alpha-Ergokryptine (CB 154).

Authors:  E Billeter; E Flückinger
Journal:  Experientia       Date:  1971-04-15

5.  Effects of 2-BR-alpha-ergokryptine (CB 154) on sex-linked rejection of pituitary isografts in female C57BL mice.

Authors:  K Hoshino
Journal:  Experientia       Date:  1973

6.  Network pharmacology exploration reveals the bioactive compounds and molecular mechanisms of Li-Ru-Kang against hyperplasia of mammary gland.

Authors:  Shizhang Wei; Xuelin Zhou; Ming Niu; Haizhu Zhang; Xiaoyi Liu; Ruilin Wang; Pengyan Li; Haotian Li; Huadan Cai; Yanling Zhao
Journal:  Mol Genet Genomics       Date:  2019-05-03       Impact factor: 3.291

7.  Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

Authors:  G M Besser; L Parke; C R Edwards; I A Forsyth; A S McNeilly
Journal:  Br Med J       Date:  1972-09-16

8.  Bromocriptine therapy in acromegaly. A long-term review of 35 cases.

Authors:  Y Sachdev; K Gopal; V K Garg
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.